← Evidence map

TrialPharmacoEconomics1999

Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALS.

S J Ackerman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

1999

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled itcites it

Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALS. | OpenQuestion